1. Home
  2. SELX vs NSRX Comparison

SELX vs NSRX Comparison

Compare SELX & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SELX

Semilux International Ltd. Ordinary Shares

HOLD

Current Price

$0.44

Market Cap

24.0M

Sector

N/A

ML Signal

HOLD

NSRX

Nasus Pharma Ltd. Ordinary Shares

SELL

Current Price

$3.57

Market Cap

25.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SELX
NSRX
Founded
2021
2019
Country
Taiwan
Israel
Employees
N/A
7
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.0M
25.8M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
SELX
NSRX
Price
$0.44
$3.57
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$19.67
AVG Volume (30 Days)
3.3M
93.3K
Earning Date
05-08-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.23
$1.98
52 Week High
$1.85
$9.99

Technical Indicators

Market Signals
Indicator
SELX
NSRX
Relative Strength Index (RSI) 50.75 58.74
Support Level $0.32 $2.04
Resistance Level $0.78 $5.20
Average True Range (ATR) 0.06 0.38
MACD 0.01 0.26
Stochastic Oscillator 53.08 61.51

Price Performance

Historical Comparison
SELX
NSRX

About SELX Semilux International Ltd. Ordinary Shares

Semilux International Ltd is a company that operates through its subsidiaries which is an optical and 3D sensing technology company that is involved in the customization, design and supply of optical components and integrated chip for various industries including autonomous driving, intelligent lighting, as well as unmanned aerial vehicles. In collaboration with its clients, TCO conceptualizes and produces high precision optics and sensing modules that are specifically customized to clients' needs for ease of integration in overall design and production. Applications for TCO's products include automotive laser headlight systems, adaptive driving beams (ADB) as well as light detection and autonomous driving systems (LiDAR).

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: